Sirona Biochem Corp
2:30 PM - 2:45 PM (EDT), Monday, June 5, 2023 ・ Session Room 104C
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Through its wholly-owned French subsidiary TFChem, the Company specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. Sirona Biochem’s business model is to develop active ingredients that are then licensed out for up front payments, milestones and royalties.
Ticker:
SBM
Exchange:
TSX.V
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
British Columbia
Company HQ Country:
Canada
Year Founded:
2009
Main Therapeutic Focus:
Multiple Therapeutics
Lead Product in Development:
TFC-039 or TFC-1067
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
